Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice

European Journal of Pharmacology

Volumn 476, Issue 1-2, 2003, Pages 71-77

  De Groote, Lotte ^a,b   Olivier, Berend ^b,c   Westenberg, Herman G M ^a,b,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); Autoreceptor; Caudate putamen; CP 93,129; Fluvoxamine; Heteroreceptor; Selective reuptake inhibitor

Indexed keywords

3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; AUTORECEPTOR; DOPAMINE; FENFLURAMINE; FLUVOXAMINE MALEATE; RITANSERIN; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TETRODOTOXIN; 3 (1,2,5,6 TETRAHYDROPYRID 4 YL)PYRROLO(3,2 B)PYRID 5 ONE; 3-(1,2,5,6-TETRAHYDROPYRID-4-YL)PYRROLO(3,2-B)PYRID-5-ONE; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOSE RESPONSE; EXTRACELLULAR SPACE; GENOTYPE; IN VIVO STUDY; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; WILD TYPE; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; ELECTROCHEMISTRY; EXTRACELLULAR FLUID; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MOUSE MUTANT; TIME;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; ELECTROCHEMISTRY; EXTRACELLULAR FLUID; GENOTYPE; MALE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; PYRIDINES; PYRROLES; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN; SEROTONIN AGONISTS; TIME FACTORS;

EID: 0142231505     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02154-X     Document Type: Article

References (38)

1. Abellan M.T., Martin-Ruiz R., Artigas F. Local modulation of the 5-HT release in the dorsal striatum of the rat: an in vivo microdialysis study. Eur. Neuropsychopharmacol. 10:2000;455-462.
2. Ase A.R., Reader T.A., Hen R., Riad M., Descarries L. Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice. J. Neurochem. 75:2000;2415-2426.
3. Bengel D., Johren O., Andrews A.M., Heils A., Mossner R., Sanvitto G.L., Saavedra J.M., Lesch K.P., Murphy D.L. Cellular localization and expression of the serotonin transporter in mouse brain. Brain Res. 778:1997;338-345.
4. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
5. Benloucif S., Keegan M.J., Galloway M.P. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265:1993;373-377.
6. Bentue-Ferrer D., Reymann J.M., Rousselle J.C., Massot O., Bourin M., Allain H., Fillion G. 5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis. Eur. J. Pharmacol. 358:1998;129-137.
7. Bonhomme N., De Deurwaerdere P., Le Moal M., Spampinato U. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane- anesthetized rat. Neuropharmacology. 34:1995;269-279.
8. Boschert U., Amara D.A., Segu L., Hen R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience. 58:1994;167-182.
9. Bruinvels A.T., Landwehrmeyer B., Gustafson E.L., Durkin M.M., Mengod G., Branchek T.A., Hoyer D., Palacios J.M. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology. 33:1994;367-386.
10. Cameron D.L., Williams J.T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14:1994;6763-6767.
11. De Deurwaerdere P., Bonhomme N., Le Moal M., Spampinato U. d-Fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. J. Neurochem. 65:1995;1100-1108.
12. De Groote L., Olivier B., Westenberg H.G.M. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT1B receptor knockout mice. Eur. J. Pharmacol. 439:2002;93-100.
13. 1B autoreceptors: a microdialysis study in knockout mice. Psychopharmacology. 162:2002;419-424.
14. Franklin G.T., Paxinos K.B. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego, CA.
15. Galloway M.P., Suchowski C.S., Keegan M.J., Hjorth S. Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse. 15:1993;90-92.
16. Iyer R.N., Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J. Pharmacol. Exp. Ther. 277:1996;40-47.
17. Johnson S.W., Mercuri N.B., North R.A. 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons. J. Neurosci. 12:1992;2000-2006.
18. Knobelman D.A., Kung H.F., Lucki I. Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors. J. Pharmacol. Exp. Ther. 292:2000;1111-1117.
19. Knobelman D.A., Hen R., Lucki I. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1a) and 5-hydroxytryptamine(1b) autoreceptors in different brain regions of the mouse. J. Pharmacol. Exp. Ther. 298:2001;1083-1091.
20. Lucas G., De Deurwaerdere P., Porras G., Spampinato U. Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated. Neuropharmacology. 39:2000;1984-1995.
21. Lucas G., Di Matteo V., De Deurwaerdere P., Porras G., Martin-Ruiz R., Artigas F., Esposito E., Spampinato U. Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. Eur. J. Neurosci. 13:2001;889-898.
22. Lucas J.J., Segu L., Hen R. 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. Mol. Pharmacol. 51:1997;755-763.
23. Macor J.E., Burkhart C.A., Heym J.H., Ives J.L., Lebel L.A., Newman M.E., Nielsen J.A., Ryan K., Schulz D.W., Torgersen L.K. 3-(1,2,5,6-Tetrahydropyrid- 4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6- tetrahydropyrid-4-yl)indole. J. Med. Chem. 33:1990;2087-2093.
24. Morikawa H., Manzoni O.J., Crabbe J.C., Williams J.T. Regulation of central synaptic transmission by 5-HT(1B) receptors. Mol. Pharmacol. 58:2000;1271-1278.
25. Ng N.K., Lee H.S., Wong P.T. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors. J. Neurosci. Res. 55:1999;600-607.
26. Rocha B.A., Scearce-Levie K., Lucas J.J., Hiroi N., Castanon N., Crabbe J.C., Nestler E.J., Hen R. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature. 393:1998;175-178.
27. Sarhan H., Fillion G. Differential sensitivity of 5-HT1B auto and heteroreceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 360:1999;382-390.
28. Sarhan H., Grimaldi B., Hen R., Fillion G. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 361:2000;12-18.
29. Sari Y., Miquel M.C., Brisorgueil M.J., Ruiz G., Doucet E., Hamon M., Verge D. Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience. 88:1999;899-915.
30. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., Buhot M.C., Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science. 265:1994;1875-1878.
31. Scearce-Levie K., Chen J.P., Gardner E., Hen R. 5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders. Ann. N.Y. Acad. Sci. 868:1999;701-715.
32. Shippenberg T.S., Hen R., He M. Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the serotonin(1B) receptor. J. Neurochem. 75:2000;258-265.
33. Soubrie P., Reisine T.D., Glowinski J. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience. 13:1984;605-625.
34. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience. 6:1981;557-618.
35. Tao R., Ma Z., Auerbach S.B. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin. J. Pharmacol. Exp. Ther. 294:2000;571-579.
36. Thorre K., Ebinger G., Michotte Y. 5-HT4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis study. Brain Res. 796:1998;117-124.
37. Yadid G., Pacak K., Kopin I.J., Goldstein D.S. Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther. 270:1994;1158-1165.
38. Yan Q., Yan S. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur. J. Pharmacol. 418:2001;55-64.